Session 5 | Precision Oncology
Section outline
-
Session 5 – 9/30/26 – Precision Oncology
Question: How do we turn cancer biology into treatment?
Topics covered in class:
o Actionable oncogenic drivers;
o Biomarkers;
o Traditional therapies;
o Targeted therapies;
o Immuno-therapies;
o Response & Acquired Resistance;
o Limitations of precision oncology;
Paper to discuss:
Cercek et al., NEJM (2025) — Nonoperative Management of Mismatch Repair–Deficient Tumors
-